| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $418.8M | -20.5% |
| Cost of Revenue | $131.5M | -35.6% |
| Gross Profit | $287.3M | -11.1% |
| R&D Expense | $1.6M | -40.7% |
| SG&A Expense | $49.2M | -15.1% |
| Operating Income | -$66.2M | +53.0% |
| Interest Expense | $6.9M | -22.4% |
| Pre-tax Income | -$71.4M | +53.2% |
| Income Tax | $239K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.2M | -39.6% |
| Accounts Receivable | $1.4M | +14.1% |
| Inventory | $16.3M | -34.7% |
| Current Assets | $78.7M | -34.0% |
| Total Assets | $174.6M | -36.9% |
| Current Liabilities | $127.6M | -22.7% |
| Long-term Debt | $21.6M | -38.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.6M | +111.4% |
| Capital Expenditures | $4.5M | -30.9% |
| Investing Cash Flow | $1.1M | +109.8% |
| Financing Cash Flow | -$15.9M | -15.7% |
| Free Cash Flow | -$2.0M | +93.2% |
| +545.9% |
| Net Income | -$71.6M | +53.1% |
| EPS (Basic) | -$10.51 | +57.0% |
| EPS (Diluted) | -$10.51 | +57.0% |
| Total Liabilities |
| $146.4M |
| -24.6% |
| Stockholders' Equity | $28.2M | -66.0% |